What is Humana's cash & equivalents?

Humana (HUM) reported cash & equivalents of $4.95B in Q1 2026.

How has Humana's cash & equivalents changed year-over-year?

Humana's cash & equivalents increased by 16.5% year-over-year, from $4.25B to $4.95B.

What is the long-term trend for Humana's cash & equivalents?

Over 5 years (2020 to 2025), Humana's cash & equivalents has grown at a -2.1% compound annual growth rate (CAGR), from $4.67B to $4.2B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Humana HUM Cash & Equivalents

Cash & Equivalents at other companies

CVS HealthCVS

$9.77B-5.6%

UnitedHealth GroupUNH

$28B-8.8%

HCA HealthcareHCA

$940M-11.3%

CenteneCNC

$21.26B+43.5%

Elevance HealthELV

$9.66B+28.8%

Molina HealthcareMOH

$5.31B+9.4%

Other financials

Income statement

See full

Revenue$39.6B+23.5%

Operating income$1.8B-12.9%

Net income$1.2B-4.7%

EPS (diluted)$9.83-4.6%

Balance sheet

See full

Total debt$14.0B+5.2%

Total equity$18.6B+4.7%

Total assets$55.3B+8.5%

Cash flow

See full

Operating cash flow$1.3B+279%

CapEx$121.0M+27.4%

Free cash flow$1.1B+380%

Valuation

See full

Market cap$46.08B+59.9%

Enterprise value$55.13B+47.5%

P/E14.5×-1.8×

P/S0.3×+0.1×

Profitability

See full

Operating margin2.7%-1.7pp

Net margin3%-0.1pp

FCF margin4.2%—

Returns & leverage

See full

Return on equity18.2%+0.9pp

Debt / equity0.8×0.0×

Current ratio1.8×-0.1×

Where this comes from

Reported directly by Humana in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Humana’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Humana's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Humana's cash & equivalents?: Humana (HUM) reported cash & equivalents of $4.95B in Q1 2026.
How has Humana's cash & equivalents changed year-over-year?: Humana's cash & equivalents increased by 16.5% year-over-year, from $4.25B to $4.95B.
What is the long-term trend for Humana's cash & equivalents?: Over 5 years (2020 to 2025), Humana's cash & equivalents has grown at a -2.1% compound annual growth rate (CAGR), from $4.67B to $4.2B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.